Shares of Victrex plc (LON:VCT) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2,127.44 and traded as high as $2,148.00. Victrex shares last traded at $2,140.00, with a volume of 118,344 shares.
VCT has been the topic of a number of recent analyst reports. Stifel Nicolaus lowered Victrex to a “hold” rating and decreased their target price for the stock from GBX 2,255 ($29.47) to GBX 2,125 ($27.77) in a report on Friday, September 27th. UBS Group reissued a “neutral” rating on shares of Victrex in a report on Friday, July 26th. Peel Hunt reissued a “hold” rating on shares of Victrex in a report on Monday, September 16th. Liberum Capital reissued a “buy” rating on shares of Victrex in a report on Monday, October 7th. Finally, Barclays raised Victrex to an “equal weight” rating and set a GBX 2,020 ($26.39) target price on the stock in a report on Wednesday, August 21st. Eight research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Victrex currently has an average rating of “Hold” and a consensus price target of GBX 2,269.50 ($29.66).
The firm has a market capitalization of $1.85 billion and a price-to-earnings ratio of 18.59. The business has a fifty day moving average of GBX 2,078.80 and a two-hundred day moving average of GBX 2,127.44.
Victrex Company Profile (LON:VCT)
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
See Also: What is included in the gross domestic product?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.